About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Appendix 3X Notices – Three New Directors
April 22, 2015
Click here to read more
Post navigation
Previous Post
Phosphagenics Initiates Oxycodone Patch Dosing in Phase 2 Clinical Trial
Next Post
Notice of 2015 Annual General Meeting
Related Posts
Placement to Advance Phase III Clinical Trial
August 28, 2023
August 28, 2023
Phosphagenics Provides Update on TPM Propofol Development Program
November 9, 2017
Updated Non-Confidential Presentation CEO USA Roadshow
August 13, 2018